Zogenix, Inc. v. Federal Insurance Company

CourtDistrict Court, N.D. California
DecidedSeptember 3, 2021
Docket4:20-cv-06578
StatusUnknown

This text of Zogenix, Inc. v. Federal Insurance Company (Zogenix, Inc. v. Federal Insurance Company) is published on Counsel Stack Legal Research, covering District Court, N.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Zogenix, Inc. v. Federal Insurance Company, (N.D. Cal. 2021).

Opinion

1 2 3 4 UNITED STATES DISTRICT COURT 5 NORTHERN DISTRICT OF CALIFORNIA 6 EUREKA DIVISION 7 8 ZOGENIX, INC., Case No. 20-cv-06578-YGR (RMI)

9 Plaintiff, ORDER RE: DISCOVERY DISPUTES 10 v. Re: Dkt. Nos. 54, 64-3 11 FEDERAL INSURANCE COMPANY, 12 Defendant.

13 14 Now pending before the court are a pair of jointly filed letter briefs setting forth each 15 Party’s request to compel certain discovery. On August 4, 2021, the Parties initially filed a 7-page 16 letter brief coupled with 23 pages of exhibits. See Ltr. Br. (dkt. 54). Thereafter, on August 11, 17 2021, the Honorable Yvonne Gonzalez Rogers referred the resolution of discovery disputes in this 18 case to the undersigned. See Order (dkt. 55). A discovery hearing was held on August 18, 2021 19 (dkt. 57); in the course of which, the undersigned rendered a series of preliminary rulings granting 20 Defendant’s motion to compel and denying Plaintiff’s motion to compel (Plaintiff’s request for 21 reinsurance information was denied as irrelevant, its request for drafting histories was granted only 22 to the extent that Defendant would produce a specific verified response, and its request regarding 23 Defendant’s position with respect to other insured entities was denied on both relevance and undue 24 burden and proportionality grounds). See Tr. (dkt. 60) at 48-49. Plaintiff’s counsel then expressed 25 dissatisfaction with his opportunity to make an adequate record as such: “I mean, we had two 26 pages to address a whole swath of requests.” Id. at 50. Consequently, the undersigned permitted 27 the Parties to file a supplemental letter brief without any page limitations whatsoever, setting forth 1 the production of that item should be compelled. See Order (dkt. 59). Shortly thereafter, the Parties 2 filed a 30-page letter brief (single spaced, and attended with approximately 60 pages of exhibits) 3 setting forth their positions regarding 16 disputed items. See Supp. Ltr. Br. (dkt. 64-3) at 1-99. For 4 the reasons stated below, the court will now convert each of its preliminary rulings in to final 5 rulings as memorialized herein. 6 BACKGROUND 7 Plaintiff has manufactured, marketed, and sold hydrocodone bititrate, an opioid 8 medication; as a result of this, Plaintiff has been sued by various entities, in various courts, 9 seeking to hold Plaintiff liable for actions and omissions that allegedly contributed to the national 10 opioid crisis (to wit, the fact that a large number of consumers became addicted to these 11 medications). See generally Compl. (dkt. 1) at 5-7. Plaintiff had purchased a series of insurance 12 policies, under which it expected to be defended in such underlying actions, and when Defendant 13 refused, Plaintiff initiated the instant lawsuit. Id. at 5-9. Through this lawsuit, Plaintiff contends: 14 (A) that Defendant “has breached its obligations under the Policies by refusing to timely and fully 15 defendant Plaintiff against the claims asserted” in the underlying lawsuits – that is, a breach of the 16 contractual duty to defend; (B) that it is entitled to declaratory relief based on Defendant’s alleged 17 breach of its duties to defend Plaintiff in the underlying lawsuits pursuant to two of the insurance 18 policies in question; and, (C) that Defendant has breached the contractual covenant of good faith 19 and fair dealing “by engaging in unreasonable conduct, including . . . improperly giv[ing] greater 20 weight to its own interest in avoiding its defense obligation than it accorded to Plaintiff’s interest 21 in a prompt and complete defense” regarding the underlying actions. Id. at 9-12. Accordingly, this 22 lawsuit boils down to two declaratory causes of action, and two causes of action for breach of 23 contractual duties and covenants. 24 Through its portion of the Joint Case Management Statement filed on January 15, 2021, 25 Plaintiff suggested that the discovery process in this case should be either bifurcated or phased in 26 such a manner as to allow “[a] motion for summary judgment by Zogenix or coordinated party 27 cross-motions on this [single] legal issue [to wit, the issue of Federal’s alleged duty to defend 1 benefit of narrowing the issues for all remaining discovery, streamline the presentation of evidence 2 in subsequent motions and at trial, and provide early guidance to the Parties on the contractual 3 obligations under the Policies that may facilitate informal resolution.” See Joint Case Mgmt. 4 Statement (dkt. 36) at 4. Plaintiff’s suggestion was rejected by Judge Gonzalez Rogers in that the 5 court’s ensuing Case Management and Pretrial Order (dkt. 41) set forth a single cutoff date for fact 6 discovery (October 22, 2021), and a single due date for summary judgment motions (December 7 14, 2021). Id. at 1. Knowing this, and without having ever having moved Judge Gonzalez Rogers 8 for a stay of the entire case, or a stay of some fraction of the discovery, or an extension of the 9 rapidly approaching discovery cutoff date, Plaintiff’s opposition to Defendant’s motion to compel 10 discovery now asks a referral judge to essentially upend a case schedule established by the 11 presiding judge by imposing an indefinite discovery stay when doing so would clearly trespass 12 into the presiding judge’s prerogative. Indeed, Plaintiff’s request is even further undermined by 13 the fact Plaintiff’s previously-proposed approach to bifurcating or phasing the discovery process 14 in this case has already been rejected by the presiding judge. 15 DISCUSSION 16 To borrow Defendant’s phrasing, the essence of Plaintiff’s resistance to providing 17 discovery in this case is embodied in Plaintiff’s assertion that it gets “to pick and choose what it 18 must produce in discovery while pressing forward with its claims” against Defendant. See Supp. 19 Ltr. Br. (dkt. 64-3) at 5. In support of this approach, Plaintiff principally relies on two state court 20 cases – whose holdings are more procedural than substantive – which the undersigned finds to be 21 inapplicable in the present context for a number of reasons. In this regard, Plaintiff relies in part on 22 Montrose Chemical Corp. v. Superior Court, 6 Cal. 4th 287 (1993). However, the undersigned 23 finds that reliance on that citation does not compel the results urged by Plaintiff. The Montrose 24 Chemical litigation focused on procedural, rather than substantive, matters. From the late 1940s to 25 the early 1980s, Montrose Chemical Corporation of California manufactured the insecticide 26 dichlorodiphenyltrichloroethane (commonly referred to as “DDT”), as a result of which, it was 27 named as a defendant in several private and governmental environmental contamination actions; 1 Montrose Chem. Corp. v. Superior Court (Canadian Universal Ins. Co.), 25 Cal. App. 4th 902, 2 905 (1994). In 1986, Montrose became concerned about its insurers’ reservation of rights and 3 decided to sue its carriers for a declaration of its rights to (1) a defense and (2) indemnity in the 4 contamination actions. Id. The appellate issues in that litigation eventually morphed into the 5 question of whether the declaratory action against the insurers could be set for trial before the third 6 party suits were resolved; in which regard the Montrose-II court held that, “on the record before 7 us, we cannot say one way or the other, and we therefore return the ball to the trial court, with 8 directions to determine the status of the underlying lawsuits and the scope of the carriers’ 9 defenses, and then decide whether it is appropriate to set this case for trial.” Id.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Wayman v. Southard
23 U.S. 1 (Supreme Court, 1825)
Erie Railroad v. Tompkins
304 U.S. 64 (Supreme Court, 1938)
Montrose Chemical Corp. v. Superior Court
861 P.2d 1153 (California Supreme Court, 1993)
Haskel, Inc. v. Superior Court
33 Cal. App. 4th 963 (California Court of Appeal, 1995)
Montrose Chem. Corp. v. SUPERIOR CT.(CANADIAN UNIV.)
25 Cal. App. 4th 902 (California Court of Appeal, 1994)
Gasperini v. Center for Humanities, Inc.
518 U.S. 415 (Supreme Court, 1996)
Riddell, Inc. v. Superior Court of L. A. Cnty.
222 Cal. Rptr. 3d 384 (California Court of Appeals, 5th District, 2017)

Cite This Page — Counsel Stack

Bluebook (online)
Zogenix, Inc. v. Federal Insurance Company, Counsel Stack Legal Research, https://law.counselstack.com/opinion/zogenix-inc-v-federal-insurance-company-cand-2021.